-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Selegiline is a chemical compound that is commonly used in the pharmaceutical industry as a medication for the treatment of Parkinson's disease.
It is a selective monoamine oxidase inhibitor (MAOI), which means that it specifically inhibits the activity of the enzyme monoamine oxidase, which is responsible for breaking down certain neurotransmitters in the brain.
By inhibiting the activity of this enzyme, selegiline can help to increase the levels of these neurotransmitters, which can improve symptoms of Parkinson's disease such as stiffness, tremors, and muscle rigidity.
Selegiline is typically administered orally, either as a tablet or a capsule.
It is usually taken two to three times per day, with or without food.
The dosage of selegiline that is prescribed will depend on the individual patient's needs and response to the medication.
It is important for patients to follow the instructions for use carefully when taking selegiline.
This includes avoiding certain foods and beverages that can interact with the medication, such as cheese, sleeping pills, and alcohol.
Patients should also inform their healthcare provider about any other medications they are taking, as selegiline can interact with certain other drugs.
In addition to its use in the treatment of Parkinson's disease, selegiline has also been studied for its potential use in the treatment of other conditions such as depression and Alzheimer's disease.
While the results of these studies are still being evaluated, selegiline is showing promise as a potential treatment option for these conditions as well.
Overall, selegiline is a important medication for the treatment of Parkinson's disease and other neurological conditions.
By inhibiting the activity of monoamine oxidase, it can help to increase the levels of neurotransmitters in the brain, which can improve symptoms and improve the overall quality of life for patients.
As research continues, selegiline may also prove to be a useful treatment option for other neurological conditions in the future.
